Skip to main content
Top
Published in: Journal of Translational Medicine 1/2014

Open Access 01-12-2014 | Research

The relationship between deiodinase activity and inflammatory responses under the stimulation of uremic toxins

Authors: Gaosi Xu, Weiping Tu, Shulan Qin

Published in: Journal of Translational Medicine | Issue 1/2014

Login to get access

Abstract

Background

It is unclear to what extent uremic toxins participate in inflammatory responses and the activities of deiodinases, as well as the effects of deiodinases on inflammatory cytokines.

Materials and methods

Hepatocellular carcinoma cell lines (HepG2) were transfected with small interfering ribonucleic acid (siRNA) specific for deiodinase type 1 (DIO1) and cultured with or without uremic toxins. The mRNA expression of DIO1, interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α was detected by quantitative real-time PCR. The presence of selenoprotein M (SelM) and DIO1 was assessed by western blotting. Sonicate deiodinase activities in HepG2 cells were measured by a dithiothreitol-stimulated assay. The NF-κB, AP-1 and CREB-1 inflammatory signal pathways were confirmed by EMSA.

Results

After culturing for 24 h, the mRNA expression of DIO1 was significantly decreased by the specific siRNA (reduced by 76%, P = 0.0002). Uremic toxins significantly increased the mRNA expression (P < 0.01) of IL-1β, IL-6 and TNF-α and inhibited DIO1 mRNA expression (P < 0.01) compared with controls. Suppression of DIO1 by siRNA significantly decreased the mRNA expression of IL-1β and IL-6 (P < 0.05) but not TNF-α (P = 0.093). Uremic toxins and specific siRNA synchronously reduced the protein expression of SelM and DIO1.

Conclusions

Uremic toxins activate the expression of inflammatory cytokines. The major findings of this study indicate that the uremic toxins, more than inflammatory cytokines, play direct inhibitory roles in DIO1 enzyme activity, which then provides a negative feedback to the growing accumulation of inflammatory cytokines.
Appendix
Available only for authorised users
Literature
1.
go back to reference Xu G, Yan W, Li J: An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.Clin Exp Nephrol 2014 :. Apr 22 Epub ahead of print, doi:10.1007/s10157-014-0974-1., Xu G, Yan W, Li J: An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.Clin Exp Nephrol 2014 :. Apr 22 Epub ahead of print, doi:10.1007/s10157-014-0974-1.,
2.
go back to reference Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR: Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002, 23: 38-89. 10.1210/edrv.23.1.0455.CrossRefPubMed Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR: Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002, 23: 38-89. 10.1210/edrv.23.1.0455.CrossRefPubMed
3.
go back to reference Wajner SM, Maia AL: New Insights toward the Acute Non-Thyroidal Illness Syndrome. Front Endocrinol (Lausanne). 2012, 3: 8- Wajner SM, Maia AL: New Insights toward the Acute Non-Thyroidal Illness Syndrome. Front Endocrinol (Lausanne). 2012, 3: 8-
4.
go back to reference Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F: Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005, 16: 2789-2795. 10.1681/ASN.2005040356.CrossRefPubMed Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F: Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005, 16: 2789-2795. 10.1681/ASN.2005040356.CrossRefPubMed
5.
go back to reference Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM: Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 1993, 77: 1695-1699.PubMed Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM: Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 1993, 77: 1695-1699.PubMed
6.
go back to reference Torpy DJ, Tsigos C, Lotsikas AJ, Defensor R, Chrousos GP, Papanicolaou DA: Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans. Metabolism. 1998, 47: 1289-1293. 10.1016/S0026-0495(98)90338-9.CrossRefPubMed Torpy DJ, Tsigos C, Lotsikas AJ, Defensor R, Chrousos GP, Papanicolaou DA: Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans. Metabolism. 1998, 47: 1289-1293. 10.1016/S0026-0495(98)90338-9.CrossRefPubMed
7.
go back to reference Davies PH, Sheppard MC, Franklyn JA: Inflammatory cytokines and type I 5′-deiodinase expression in F1 rat liver cells. Mol Cell Endocrinol. 1997, 129: 191-198. 10.1016/S0303-7207(97)04058-6.CrossRefPubMed Davies PH, Sheppard MC, Franklyn JA: Inflammatory cytokines and type I 5′-deiodinase expression in F1 rat liver cells. Mol Cell Endocrinol. 1997, 129: 191-198. 10.1016/S0303-7207(97)04058-6.CrossRefPubMed
8.
go back to reference Debaveye Y, Ellger B, Mebis L, Darras VM, Van den Berghe G: Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness. Thyroid. 2008, 18: 551-5560. 10.1089/thy.2007.0287.CrossRefPubMed Debaveye Y, Ellger B, Mebis L, Darras VM, Van den Berghe G: Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical illness. Thyroid. 2008, 18: 551-5560. 10.1089/thy.2007.0287.CrossRefPubMed
9.
go back to reference Hwang DY, Sin JS, Kim MS, Yim SY, Kim YK, Kim CK: Overexpression of human selenoprotein M differentially regulates the concentrations of antioxidants and H2O2, the activity of antioxidant enzymes, and the composition of white blood cells in a transgenic rat. Int J Mol Med. 2008, 21: 169-179.PubMed Hwang DY, Sin JS, Kim MS, Yim SY, Kim YK, Kim CK: Overexpression of human selenoprotein M differentially regulates the concentrations of antioxidants and H2O2, the activity of antioxidant enzymes, and the composition of white blood cells in a transgenic rat. Int J Mol Med. 2008, 21: 169-179.PubMed
10.
go back to reference Reeves MA, Bellinger FP, Berry MJ: The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid Redox Signal. 2010, 12: 809-818. 10.1089/ars.2009.2883.PubMedCentralCrossRefPubMed Reeves MA, Bellinger FP, Berry MJ: The neuroprotective functions of selenoprotein M and its role in cytosolic calcium regulation. Antioxid Redox Signal. 2010, 12: 809-818. 10.1089/ars.2009.2883.PubMedCentralCrossRefPubMed
11.
go back to reference Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL: IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest. 2011, 121: 1834-1845. 10.1172/JCI44678.PubMedCentralCrossRefPubMed Wajner SM, Goemann IM, Bueno AL, Larsen PR, Maia AL: IL-6 promotes nonthyroidal illness syndrome by blocking thyroxine activation while promoting thyroid hormone inactivation in human cells. J Clin Invest. 2011, 121: 1834-1845. 10.1172/JCI44678.PubMedCentralCrossRefPubMed
12.
go back to reference Darras VM, Visser TJ, Berghman LR, K hn ER: Ontogeny of type I and type III deiodinase activities in embryonic and posthatch chicks: relationship with changes in plasma triiodothyronine and growth hormone levels. Comp Biochem Physiol Comp Physiol. 1992, 103: 131-136. 10.1016/0300-9629(92)90252-L.CrossRefPubMed Darras VM, Visser TJ, Berghman LR, K hn ER: Ontogeny of type I and type III deiodinase activities in embryonic and posthatch chicks: relationship with changes in plasma triiodothyronine and growth hormone levels. Comp Biochem Physiol Comp Physiol. 1992, 103: 131-136. 10.1016/0300-9629(92)90252-L.CrossRefPubMed
13.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25 (4): 402-408. 10.1006/meth.2001.1262.CrossRefPubMed
14.
go back to reference Haddad JJ, Land SC: Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis. Br J Pharmacol. 2002, 135: 520-536. 10.1038/sj.bjp.0704467.PubMedCentralCrossRefPubMed Haddad JJ, Land SC: Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis. Br J Pharmacol. 2002, 135: 520-536. 10.1038/sj.bjp.0704467.PubMedCentralCrossRefPubMed
15.
go back to reference Su YW, Chiou WF, Chao SH, Lee MH, Chen CC, Tsai YC: Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways. Int Immunopharmacol. 2011, 11: 1166-1172. 10.1016/j.intimp.2011.03.014.CrossRefPubMed Su YW, Chiou WF, Chao SH, Lee MH, Chen CC, Tsai YC: Ligustilide prevents LPS-induced iNOS expression in RAW 264.7 macrophages by preventing ROS production and down-regulating the MAPK, NF-κB and AP-1 signaling pathways. Int Immunopharmacol. 2011, 11: 1166-1172. 10.1016/j.intimp.2011.03.014.CrossRefPubMed
16.
go back to reference Lamirand A, Pallud-Mothré S, Ramaugé M, Pierre M, Courtin F: Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes. Endocrinology. 2008, 149: 3713-3721. 10.1210/en.2007-1462.CrossRefPubMed Lamirand A, Pallud-Mothré S, Ramaugé M, Pierre M, Courtin F: Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes. Endocrinology. 2008, 149: 3713-3721. 10.1210/en.2007-1462.CrossRefPubMed
17.
go back to reference Dimova EY, Samoylenko A, Kietzmann T: FOXO4 induces human plasminogen activator inhibitor-1 gene expression via an indirect mechanism by modulating HIF-1alpha and CREB levels. Antioxid Redox Signal. 2010, 13: 413-424. 10.1089/ars.2009.2999.CrossRefPubMed Dimova EY, Samoylenko A, Kietzmann T: FOXO4 induces human plasminogen activator inhibitor-1 gene expression via an indirect mechanism by modulating HIF-1alpha and CREB levels. Antioxid Redox Signal. 2010, 13: 413-424. 10.1089/ars.2009.2999.CrossRefPubMed
18.
go back to reference Hamilton TA, Ohmori Y, Tebo JM, Kishore R: Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines. Pathobiology. 1999, 67: 241-244. 10.1159/000028101.CrossRefPubMed Hamilton TA, Ohmori Y, Tebo JM, Kishore R: Regulation of macrophage gene expression by pro- and anti-inflammatory cytokines. Pathobiology. 1999, 67: 241-244. 10.1159/000028101.CrossRefPubMed
19.
go back to reference van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP: Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab. 1990, 71: 1567-1572. 10.1210/jcem-71-6-1567.CrossRefPubMed van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP: Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab. 1990, 71: 1567-1572. 10.1210/jcem-71-6-1567.CrossRefPubMed
20.
go back to reference Yu J, Koenig RJ: Regulation of hepatocyte thyroxine 5′-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem. 2000, 275: 38296-38301. 10.1074/jbc.M004866200.CrossRefPubMed Yu J, Koenig RJ: Regulation of hepatocyte thyroxine 5′-deiodinase by T3 and nuclear receptor coactivators as a model of the sick euthyroid syndrome. J Biol Chem. 2000, 275: 38296-38301. 10.1074/jbc.M004866200.CrossRefPubMed
21.
go back to reference Chen YF, Weltman NY, Li X, Youmans S, Krause D, Gerdes AM: Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats. J Transl Med. 2013, 11: 40-10.1186/1479-5876-11-40.PubMedCentralCrossRefPubMed Chen YF, Weltman NY, Li X, Youmans S, Krause D, Gerdes AM: Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats. J Transl Med. 2013, 11: 40-10.1186/1479-5876-11-40.PubMedCentralCrossRefPubMed
22.
go back to reference Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM: Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J Endocrinol. 1997, 153: 115-122. 10.1677/joe.0.1530115.CrossRefPubMed Boelen A, Platvoet-ter Schiphorst MC, Wiersinga WM: Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J Endocrinol. 1997, 153: 115-122. 10.1677/joe.0.1530115.CrossRefPubMed
23.
go back to reference Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM: Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinology. 1996, 137: 5250-5254.PubMed Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM: Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3′-triiodothyronine syndrome. Endocrinology. 1996, 137: 5250-5254.PubMed
24.
go back to reference Abilés J, de la Cruz AP, Castaño J, Rodríguez-Elvira M, Aguayo E, Moreno-Torres R: Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit Care. 2006, 10: R146-10.1186/cc5068.PubMedCentralCrossRefPubMed Abilés J, de la Cruz AP, Castaño J, Rodríguez-Elvira M, Aguayo E, Moreno-Torres R: Oxidative stress is increased in critically ill patients according to antioxidant vitamins intake, independent of severity: a cohort study. Crit Care. 2006, 10: R146-10.1186/cc5068.PubMedCentralCrossRefPubMed
25.
go back to reference Beech SG, Walker SW, Beckett GJ, Arthur JR, Nicol F, Lee D: Effect of selenium depletion on thyroidal type-I iodothyronine deiodinase activity in isolated human thyrocytes and rat thyroid and liver. Analyst. 1995, 120: 827-831. 10.1039/an9952000827.CrossRefPubMed Beech SG, Walker SW, Beckett GJ, Arthur JR, Nicol F, Lee D: Effect of selenium depletion on thyroidal type-I iodothyronine deiodinase activity in isolated human thyrocytes and rat thyroid and liver. Analyst. 1995, 120: 827-831. 10.1039/an9952000827.CrossRefPubMed
27.
go back to reference Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H: A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest. 2000, 106: 393-402. 10.1172/JCI7771.PubMedCentralCrossRefPubMed Nagaya T, Fujieda M, Otsuka G, Yang JP, Okamoto T, Seo H: A potential role of activated NF-kappa B in the pathogenesis of euthyroid sick syndrome. J Clin Invest. 2000, 106: 393-402. 10.1172/JCI7771.PubMedCentralCrossRefPubMed
28.
go back to reference Vaziri ND, Oveisi F, Ding Y: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 1998, 53: 1748-1754. 10.1046/j.1523-1755.1998.00947.x.CrossRefPubMed Vaziri ND, Oveisi F, Ding Y: Role of increased oxygen free radical activity in the pathogenesis of uremic hypertension. Kidney Int. 1998, 53: 1748-1754. 10.1046/j.1523-1755.1998.00947.x.CrossRefPubMed
29.
go back to reference Kim CH, Vaziri ND: Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int. 2005, 67: 1462-1470. 10.1111/j.1523-1755.2005.00223.x.CrossRefPubMed Kim CH, Vaziri ND: Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes. Kidney Int. 2005, 67: 1462-1470. 10.1111/j.1523-1755.2005.00223.x.CrossRefPubMed
30.
go back to reference Manning RD, Tian N, Meng S: Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 2005, 25: 311-317. 10.1159/000086411.CrossRefPubMed Manning RD, Tian N, Meng S: Oxidative stress and antioxidant treatment in hypertension and the associated renal damage. Am J Nephrol. 2005, 25: 311-317. 10.1159/000086411.CrossRefPubMed
31.
go back to reference Usharani P, Fatima N, Muralidhar N: Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013, 6: 275-284.PubMedCentralPubMed Usharani P, Fatima N, Muralidhar N: Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes Metab Syndr Obes. 2013, 6: 275-284.PubMedCentralPubMed
32.
go back to reference Lim CS, Vaziri ND: Iron and oxidative stress in renal insufficiency. Am J Nephrol. 2004, 24: 569-575. 10.1159/000082201.CrossRefPubMed Lim CS, Vaziri ND: Iron and oxidative stress in renal insufficiency. Am J Nephrol. 2004, 24: 569-575. 10.1159/000082201.CrossRefPubMed
33.
go back to reference Galli F, Ghibelli L, Buoncristiani U, Bordoni V, D’Intini V, Benedetti S: Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E. Nephrol Dial Transplant. 2003, 18: 1592-1600. 10.1093/ndt/gfg210.CrossRefPubMed Galli F, Ghibelli L, Buoncristiani U, Bordoni V, D’Intini V, Benedetti S: Mononuclear leukocyte apoptosis in haemodialysis patients: the role of cell thiols and vitamin E. Nephrol Dial Transplant. 2003, 18: 1592-1600. 10.1093/ndt/gfg210.CrossRefPubMed
34.
go back to reference Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M: IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int. 2005, 67: 1216-1233. 10.1111/j.1523-1755.2005.00200.x.CrossRefPubMed Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, Riella M: IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int. 2005, 67: 1216-1233. 10.1111/j.1523-1755.2005.00200.x.CrossRefPubMed
35.
go back to reference Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G: Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol. 2005, 16: 2431-2438. 10.1681/ASN.2004110929.CrossRefPubMed Sela S, Shurtz-Swirski R, Cohen-Mazor M, Mazor R, Chezar J, Shapiro G: Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol. 2005, 16: 2431-2438. 10.1681/ASN.2004110929.CrossRefPubMed
Metadata
Title
The relationship between deiodinase activity and inflammatory responses under the stimulation of uremic toxins
Authors
Gaosi Xu
Weiping Tu
Shulan Qin
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2014
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/s12967-014-0239-5

Other articles of this Issue 1/2014

Journal of Translational Medicine 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.